Intangible Assets

Goodwill



(In millions)	CooperVision			CooperSurgical			Total
Balance at October 31, 2017	$	1,735.7		$	619.1		$	2,354.8
Net additions during the year ended October 31, 2018	36.8			34.4			71.2
Translation	(29.6		)	(4.3		)	(33.9		)
Balance at October 31, 2018	1,742.9			649.2			2,392.1
Net additions during the six months ended April 30, 2019	13.8			22.0			35.8
Translation	11.2			(0.6		)	10.6
Balance at April 30, 2019	$	1,767.9		$	670.6		$	2,438.5

During the three months ended April 30, 2019, there was a change in the reporting units as a result of realignment in the internal reporting structure of the business around markets and customers at CooperSurgical. As such, Cooper Surgical has evolved into two reporting units, namely, Office/Surgical and Fertility, which reflects management oversight of operations. These reporting units, including CooperVision, will be tested for potential goodwill impairment annually as of the third quarter of each fiscal year. The change in reporting units did not result in a change in operating segments. We allocated CooperSurgical's goodwill based on relative fair values utilizing the discounted cash flow method and guideline public company method as our allocation base, and the allocated fair values exceeded the carrying values for each of the three reporting units as of April 30, 2019.

The Company evaluates goodwill for impairment annually during the fiscal third quarter and when an event occurs, or circumstances change such that it is reasonably possible that impairment may exist. The Company accounts for goodwill and evaluates its goodwill balances and tests them for impairment in accordance with related accounting standards. The Company performs impairment tests of goodwill at the reporting unit level, which is one level below operating segments. Reporting units are identified as components for which discrete financial information is available and is regularly reviewed by management. Under the impairment test, if a reporting unit’s carrying amount exceeds its estimated fair value, goodwill impairment is recognized to the extent that the carrying amount of goodwill exceeds the fair value of the goodwill. The Company performed its annual impairment assessment in its third quarters of fiscal 2018 and fiscal 2017 respectively, and its analysis indicated that the Company had no impairment of goodwill.

Other Intangible Assets



	April 30, 2019				October 31, 2018
(In millions)	Gross Carrying Amount		Accumulated Amortization		Gross Carrying Amount		Accumulated Amortization		Weighted Average Amortization Period (In years)

Intangible assets with definite lives:
Trademarks	$	147.8	$	22.0	$	138.1	$	16.9	14
Composite intangible asset	1,061.9		106.1		1,061.9		70.8		15
Technology	397.9		206.1		387.2		190.7		11
Customer relationships	357.7		181.3		350.0		168.6		13
License and distribution rights and other⁽¹⁾	67.3		51.9		74.9		52.7		7
	2,032.6		$	567.4	2,012.1		$	499.7	14
Less: accumulated amortization and translation	567.4				499.7
Intangible assets with definite lives, net	1,465.2				1,512.4

Intangible assets with indefinite lives, net ⁽²⁾	8.9				8.9

Total other intangible assets, net	$	1,474.1			$	1,521.3

⁽¹⁾In the second quarter of fiscal 2019, CooperSurgical sold an exclusive distribution right to distribute Filshie Clip System in the U.S. for $21.0 million and recognized a gain of $19.0 million.

⁽²⁾Intangible assets with indefinite lives include trademark and technology intangible assets.

Balances include foreign currency translation adjustments.

As of April 30, 2019, the estimation of amortization expenses for intangible assets with definite lives is as follows:



Fiscal years:	(In millions)
Remainder of 2019	$	71.8
2020	135.5
2021	134.2
2022	132.4
2023	130.1
Thereafter	861.2
Total remaining amortization for intangible assets with definite lives	$	1,465.2